Inflammation 20-Plex Human ProcartaPlex™ Panel

Catalog number: EPX200-12185-901

Inflammation 20-Plex Human ProcartaPlex™ Panel

Catalog number: EPX200-12185-901
Catalog Number
Unit Size
96 tests
Price (USD)
Price: 4,105.00
Your Price:
Catalog NumberUnit SizePrice (USD)Quantity
EPX200-12185-90196 tests
Price: 4,105.00
Your Price:
Product Overview
Citations & References
Additional Information
The Human Inflammation 20-Plex ProcartaPlex Panel enables the exploration of immune function by analyzing 20 protein targets in a single well using Luminex xMAP technology. The overall effect of an inflammatory response is dictated by the balance between pro- and anti-inflammatory mediators. Pro-inflammatory cytokines such as IL-1 beta, IL-6, and TNF alpha are responsible for early responses and amplify inflammatory reactions, whereas anti-inflammatory cytokines, which include IL-4, IL-10, and IL-13, have the opposite effect in that they limit the inflammatory reactions. An unregulated hyperinflammatory state can lead to a cytokine storm, also called cytokine release syndrome (CRS). The increasing complexity of pro- and anti-inflammatory cytokine and chemokine networks has made it crucial to examine them in relevant functional groups rather than individually.

ProcartaPlex preconfigured panels are extensively tested for analyte combinability, interference, and cross-reactivity to provide the highest level of validation and precision. All ProcartaPlex panels are supplied with the necessary reagents to perform the assay.

ProcartaPlex multiplex panels are available in multiple formats across six species (human, mouse, rat, nonhuman primate, porcine, and canine). Visit our ProcartaPlex Immunoassays page for more information and available products.

Target list [bead region]:
Cytokines: GM-CSF [44], IFN alpha [48], IFN gamma [43], IL-1 alpha [62], IL-1 beta [18], IL-4 [20], IL-6 [25], IL-8 [27], IL-10 [28], IL-12p70 [34], IL-13 [35], IL-17A (CTLA-8) [36], TNF alpha [45]
Chemokines: IP-10 (CXCL10) [22], MCP-1 (CCL2) [51], MIP-1 alpha (CCL3) [12], MIP-1 beta (CCL4) [47]
Cell adhesion and inflammatory response: ICAM-1 [73], CD62E (E-selectin) [77], CD62P (P-Selectin) [55]

About ProcartaPlex assays for the Luminex platform
ProcartaPlex immunoassays are based on the principles of a sandwich ELISA, using two highly specific antibodies binding to different epitopes of one protein to quantitate all protein targets simultaneously using a Luminex instrument. ProcartaPlex multiplex assays require as little as 25 μL of plasma or serum, or 50 μL of cell culture supernatant, and just four hours to obtain analyzed results.

Features include:
• Reproducible, reliable results—validated as a panel to the highest industry standard, including protein target combinability and cross-reactivity testing
• More results per sample—measure multiple protein targets simultaneously in a single 25–50 μL sample
• Well-established Luminex technology highly referenced multiplexing platform for protein detection and quantitation

ProcartaPlex assays utilize Luminex xMAP (multianalyte profiling) technology for the simultaneous detection and quantitation of up to 80 protein targets in a single 25–50 μL sample—from plasma, serum, cell culture supernatants, and other bodily fluids.

The Luminex beads in the ProcartaPlex assay are internally dyed with precise proportions of red and infrared fluorophores to create spectrally unique signatures that can be identified by the Luminex xMAP detection systems (e.g., Luminex 200, FLEXMAP 3D, and MAGPIX). Similar to a sandwich ELISA, the ProcartaPlex assay uses matched antibody pairs to identify the protein of interest. In a multiplexed assay, each spectrally unique bead is labeled with antibodies specific for a single target protein, and bound proteins are identified with biotinylated antibodies and streptavidin–R-phycoerythrin (RPE). The conjugation of protein-specific antibodies to a distinct bead allows for analysis of multiple targets in a single well.

The most significant difference between a ProcartaPlex assay and ELISA is that the capture antibody in the ProcartaPlex assay is conjugated to a bead and not adsorbed to the microplate well, so the ProcartaPlex assay reagents are free-floating in the solution. For detection, the Luminex 200 instrument, for example, contains two lasers, one to distinguish the spectral signature of each bead and the second to quantify the amount of RPE fluorescence, which is proportional to the amount of protein present in the sample. ProcartaPlex multiplex assays can profile more target proteins using significantly less sample in the same time that it takes to perform a traditional sandwich ELISA.

ProcartaPlex multiplex panels are available in multiple formats across six species (human, mouse, rat, nonhuman primate, porcine, and canine). Visit for more information and available products.

For Research Use Only. Not for use in diagnostic procedures.


Product Type
Multiplex Panel
96 Tests
Assay Sensitivity
Less than 15%
Assay Range
See Certificate of Analysis
Multiplex Kit
For Use With (Equipment)
Luminex™ Instruments
Product Line
Sample Type
Serum, Plasma, Cell Culture Supernatants
Sample Volume
Serum, Plasma: 25 μL; CCS: 50 μL
Shipping Condition
Wet Ice

Contents & Storage

  • 2 vials Human Standard Mix A (lyophilized)
  • 2 vials Human Standard Mix B (lyophilized)
  • 2 vials Human Standard Mix F (lyophilized)
  • 1 vial Capture Bead Mix (1X)
  • 1 vial Biotinylated Detection Antibody Mix (50X)
  • 1 bottle Reading Buffer (1X)
  • 1 bottle Wash Buffer (10x)
  • 1 bottle Streptavidin-PE (1X)
  • 1 bottle Universal Assay Buffer (1X)
  • 1 bottle Detection Antibody Diluent (1X)
  • 8-tube strip
  • Adhesive film
  • Flat-bottom 96-well plate, black
  • Store at 2°C to 8°C